Qube Research & Technologies LTD Biogen Inc. Call Options Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$189.07 - $236.8 $2.93 Million - $3.67 Million
15,500 New
15,500 $3 Million
Q1 2024

May 14, 2024
BUY
$212.02 - $267.71 $21,202 - $26,770
100 New
100 $21,000
Q3 2023

Nov 13, 2023
BUY
$253.3 - $285.89 $4.64 Million - $5.23 Million
18,300 New
18,300 $4.7 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
126M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email